Is your child currently experiencing moderately to severely active IBD flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce diarrhea with pus, perianal fistula, cramps, frequent fevers, and/or canker sores associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Act now.

We are looking for children at least 2 years of age but under 18 to join a study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or moderate to severe UC (including associated symptoms such as recurrent diarrhea, growth failure, cramps, frequent fevers and/or liver disease), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children at least 2 years of age but under 18 may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Act now.

Is your child currently experiencing moderate to severe CD flare-ups? Local research study is testing a potential new medication to see if it may reduce diarrhea with pus, fistula, abdominal pain, frequent fevers, and/or liver disease associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.

We are looking for children to join a clinical research to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or gastrointestinal disease (including associated symptoms such as abdominal pain or cramping, joint pain, rectal pain, chronic fatigue and/or eye pain), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease (CD) research is testing a potential new medication to see if it may reduce cramping, growth failure, cramps, chronic fatigue, and/or anemia associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease (CD) research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

We are looking for young people 2 to 17 years old to join a Crohn’s disease (CD) medical research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or CD (including associated symptoms such as diarrhea with blood, persistent diarrhea, constant need to poop, malnutrition and/or canker sores), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child is eligible.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce stomach pain, inflammation of the bowel or intestine, abdominal pain, chronic fatigue, and/or liver disease associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for child to join a Crohn’s disease (CD) clinical trial to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or moderately to severely active ulcerative colitis (including associated symptoms such as joint pain, persistent diarrhea, abdominal pain, frequent fevers and/or anemia), consider one of our GI medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the GI medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce painful joints, iron deficiency, abdominal pain, malnutrition, and/or liver disease associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people aged 2 to 17 years to join a Crohn’s disease medical research study to help us discover more about treating moderate to severe ulcerative colitis. If you are looking for a potential new treatment option for moderate to severe ulcerative colitis or moderately to severely active IBD (including associated symptoms such as long-term diarrhea, iron deficiency, bloody stool, chronic fatigue and/or joint pain), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the CD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.